Why PVC-Free Matters — Clinical Advantages

Traditional IV bags are made from polyvinyl chloride (PVC) that requires plasticizers — most commonly DEHP (di-2-ethylhexyl phthalate) — to achieve flexibility. DEHP can leach from the bag into the IV solution, particularly when lipophilic drugs are infused or when the bag is exposed to heat or extended storage. Fleboflex eliminates this concern entirely.

DEHP is classified as a probable human carcinogen and endocrine disruptor. While exposure levels from a single IV bag are typically below regulatory thresholds, cumulative exposure across multiple infusion sessions — common in wellness and recurring treatment protocols — is a growing clinical concern. PVC-free containers remove this variable entirely.

Polypropylene demonstrates superior chemical compatibility compared to PVC. Drugs such as nitroglycerin, diazepam, and certain chemotherapy agents are known to adsorb onto PVC surfaces, reducing delivered dose. Fleboflex maintains full drug potency by eliminating surface adsorption — this is particularly important when administering high-value wellness formulations.

From an environmental perspective, PVC manufacturing and disposal generate dioxins and other persistent organic pollutants. Polypropylene is readily recyclable and does not produce toxic byproducts during incineration. For clinics promoting wellness and sustainability, PVC-free IV containers align brand values with clinical practice.

Bridge recommends educating patients on the PVC-free advantage when discussing infusion quality. Patients in wellness settings are typically informed consumers who appreciate premium, safer materials — the Fleboflex PVC-free distinction supports patient confidence and clinical differentiation.